Abstract
In most pharmaceutical and biotechnology companies, high throughput screening (HTS) is a central function in the drug-discovery process. This has resulted from the fact that there are increasing numbers of validated therapeutic targets being discovered through advances in human genomics, and increasing numbers of chemical compounds being produced through high-throughput chemistry initiatives. Many large companies study 100 targets or more each year, and in order to progress these targets, lead compounds must be found. Increasingly, pharmaceutical companies are relying on HTS as the primary engine driving lead discovery.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stadel J. M. Wilson S., and Bergsma D. J. (1997) Orphan G protein-coupled receptors: a neglected opportunity for pioneer drug discovery. Trends Pharmacol. Sci. 18, 430–437.
Cascieri M. A., and Springer M. S. (2000) The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention. Curr. Opin. Chem. Biol. 4, 420–427.
Miller W. H., Alberts D. P., Bhatnagar P. K., et al. (2000) Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic. J. Med. Chem. 43, 22–26.
Gonzalez J. E., Oades K., Leychkis Y., Harootunian A., and Negulescu P. A. (1999) Cell-based assays and instrumentation for screening ion-channel targets. Drug Discov. Today 4, 431–439.
Schroeder K. S., and Neagle B. D. (1996) FLIPR: a new instrument for accurate, high throughput optical screening. J. Biomol. Screen. 1, 75–80.
Hertzberg R. P., and Pope A. J. (2000) High throughput screening: new technology for the 21st century. Curr. Opin. Chem. Biol. 4, 45–451.
Pope A. J., Haupts U., and Moore K. J. (1999) Homogeneous fluorescence readouts for miniaturized high-throughput screening: theory and practice. Drug Discov. Today 4, 350–362.
Ullman D., Busch M., and Mander T. (1999) Fluorescence correlation spectroscopybased screening technology. J. Pharm. Technol. 99, 30–40.
Cheng Y. C., and Prussof W. (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099–3108.
Bush K. (1983) Screening and characterization of enzyme inhibitors as drug candidates. Drug Metab. Rev. 14, 689–708.
Macarron R., Mensah L., Cid C., et al. (2000) A homogeneous method to measure aminoacyl-tRNA synthetase aminoacylation activity using scintillation proximity assay technology. Anal. Biochem. 284, 183–190.
Tipton K. F. (1980) Kinetics and enzyme inhibition studies, in Enzyme Inhibitors as Drugs (Sandler, M., ed.) University Park Press, Baltimore, MD.
Burt D. (1986) Receptor binding methodology and analysis, in Receptor Binding in Drug Research (O’Brien R. A., ed.) Marcel Dekker, NY, pp. 4–29.
Lutz M.W., Menius J.A., et al. (1996) Experimental design for high-throughput screening. Drug Discov. Today 1, 277–286.
Taylor P., Stewart F., et al (2000) Automated assay optimization with integrated statistics and smart robotics. J. Biomol. Screen. 5, 213–225.
Zhang J. H., Chung T. D. Y., and Oldenburg K. R. (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4, 67–73.
Barnett V. (1974) Elements of sampling theory English Universities Press, London, pp. 42–46.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc.
About this protocol
Cite this protocol
Macarrón, R., Hertzberg, R.P. (2002). Design and Implementation of High Throughput Screening Assays. In: Janzen, W.P. (eds) High Throughput Screening. Methods in Molecular Biology™, vol 190. Humana Press. https://doi.org/10.1385/1-59259-180-9:001
Download citation
DOI: https://doi.org/10.1385/1-59259-180-9:001
Publisher Name: Humana Press
Print ISBN: 978-0-89603-889-9
Online ISBN: 978-1-59259-180-0
eBook Packages: Springer Protocols